Allergy and COVID-19
- PMID: 34842592
- PMCID: PMC9431895
- DOI: 10.23750/abm.v92iS7.12402
Allergy and COVID-19
Abstract
The first cases of as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been reported in Wuhan, China in December 2019. The World Health Organization declared the global pandemic in March 2020. Coronavirus disease 2019 (COVID-19) showed high rates of mortality in the adult population, whereas a mild course was observed in childhood. Allergic diseases, characterized by a type-2 polarization of the immune system, were considered one of the major risk factor of severe COVID-19. Large amounts of clinical data and expert opinions have been collected since the pandemic outbreak. This review summarizes the latest insights on COVID-19 and allergy.
References
-
- World health Organization. WHO Coronavirus (COVID-19) Dashboard. Available online at:https://covid19.ho.int/ . Accessed on 30 May 2021
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
